Research across Adnexal Diseases
Related studies from across the Adnexal Diseases family.
Pembrolizumab Plus Paclitaxel Improves Survival in Recurrent Ovarian Carcinoma Compared to Paclitaxel Alone
New Drug Combo Extends Survival for Tough Ovarian Cancer
This randomised, double-blind phase 3 study evaluated pembrolizumab plus paclitaxel versus placebo plus paclitaxel in 643 female participant…
This new combination offers a meaningful survival boost for women with recurrent ovarian cancer that has become resistant to standard treatm…
Systematic review and meta-analysis on LH-active gonadotropins for ovarian stimulation in infertility
Adding LH-active hormone to fertility treatment doesn't boost live births
This meta-analysis of 56 RCTs with 14,034 women found little to no difference in live birth or ongoing pregnancy when adding LH-active gonad…
For women using fertility drugs, adding LH doesn't improve live birth or pregnancy odds, but it may slightly lower egg yield without raising…
Residence in mining districts associated with higher hospitalization rates for uterine and ovarian pathologies among gynecological inpatients
Mining Towns See More Gynecology Visits
This retrospective cross-sectional study examined 4,935 gynecological inpatients at a tertiary hospital in Heilongjiang Province, China.
Women in China's mining towns face higher rates of gynecological issues like fibroids and polyps, with hospitalization rates nearly five tim…
Network meta-analysis finds GnRHa trigger reduces OHSS risk versus hCG in predicted high responders undergoing IVF
Study compares four IVF trigger methods for women at high risk of over-response
A network meta-analysis of 7 RCTs involving 632 predicted high responders undergoing IVF with GnRH antagonist protocols compared four final …
For women at high risk of painful IVF complications, a specific hormone trigger shot significantly lowers that risk without reducing egg cou…